Traders should monitor for potential negative catalysts or lack of confidence ahead of upcoming earnings or clinical updates; coordinated C-suite selling may indicate reduced conviction in near-term upside.
Price Chart
Executive Summary
Two C-suite executives at Vera Therapeutics — the Chief Regulatory Officer and Chief Commercial Officer — sold shares in a coordinated open-market transaction on February 23, 2026, realizing a combined $158,237 in proceeds. Both sold at the same price, indicating simultaneous trades, and the activity aligns with recent insider selling trends over the past 30 days.
Key Financial Metrics
Key Facts
- Chief Regulatory Officer Turner William D. sold 2,187 shares for $91,819 in open-market sale.
- Chief Commercial Officer Skelton Laurence Matthew sold 1,582 shares for $66,419 in open-market sale.
- Both trades occurred on the same day at identical price ($41.9839), indicating coordination.
- Total value of cluster: $158,237 in realized proceeds from selling activity.
- No purchases or non-cash transactions (e.g., grants, exercises) were reported in this cluster.
Financial Impact
$158,237 in insider selling with no offsetting buying
Risk Factors
- Insider selling can signal lack of confidence in future performance or valuation.
- Concentration of sales among C-suite officers increases the perceived significance of the move.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-VERA-1772067426285 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $33.67 $34.00 | ▲ +0.98% | ▲ +0.16% | $30.13 (−10.53%) |
Aug 10, 2026 7w ago | 8-K | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Aug 10, 2026 7w ago | Press Release | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Jul 9, 2026 12w ago | 8-K | $42.45 $39.12 | ▼ −7.84% | ▼ −7.71% | $30.13 (−29.03%) |
Jul 7, 2026 12w ago | 8-K | $42.96 $43.13 | ▲ +0.40% | ▼ −0.16% | $30.13 (−29.88%) |
Jun 11, 2026 16w ago | Institutional Cluster | $33.65 $35.01 | ▲ +4.04% | ▲ +3.61% | $30.13 (−10.48%) |
Jun 2, 2026 17w ago | 8-K | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
Jun 2, 2026 17w ago | Press Release | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
May 7, 2026 21w ago | 8-K | $35.88 $39.15 | ▲ +9.11% | ▲ +7.61% | $30.13 (−16.04%) |
Feb 26, 2026 31w ago | 8-K | $42.35 $38.85 | ▼ −8.26% | ▼ −7.14% | $30.13 (−28.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access